Location History:
- Nishinomiya, JP (1991 - 1994)
- Hyogo, JP (1988 - 2012)
- Amagasaki, JP (2015)
Company Filing History:
11 out of 1,001 
2 out of 67 
2 out of 2 
Years Active: 1988-2015
Title: The Innovative Contributions of Izumi Saitoh
Introduction
Izumi Saitoh is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 12 patents to his name, Saitoh's work has had a considerable impact on drug stability and efficacy.
Latest Patents
One of Saitoh's latest patents involves the crystal form of a pyrrolidylthiocarbapenem derivative. This invention presents novel crystals that exhibit excellent stability. The patent details a specific crystal of (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3[[(3S,5S)-5-(sulfamoylaminomethyl)pyrrolidin-3-yl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid. This crystal is characterized by a diffraction pattern in powder X-ray diffraction, showcasing main peaks at diffraction angles (2θ) of approximately 6.62, 13.04, 15.44, 16.58, 17.64, 20.88, 23.26, 25.02, and 25.52 degrees. Another patent also focuses on a similar crystal form, emphasizing its stability and unique diffraction pattern.
Career Highlights
Throughout his career, Saitoh has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shionogi Company Limited and Nissin Chemical Industry Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation.
Collaborations
Saitoh has collaborated with several professionals in his field, including Shohei Egawa and Shigeru Kido. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Izumi Saitoh's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of stable and effective pharmaceutical compounds.